Cellcept is a medication normally used in heart or liver transplant patients to prevent organ rejection. Cellcept lowers immune system response.
However, Cellcept has also recently been shown to be effective in slowing down the progression of Multiple Sclerosis. Several clinical trials are in progress combining Cellcept with the subcutaneous interferon treatment Avonex. Results are promising, and could potentially be a viable treatment for patients with Primary-Progressive MS (PPMS). Cellcept is also an off-label treatment for lupus. It is an effective immunosuppresent.
Mycophenolate is already a generic name of the original drug Cellcept. The active ingredient is mycophenolate mofetil.
Yes, Cellcept (mycophenolate mofetil) and Actigall (ursodiol) can generally be taken together, but it is important to consult with a healthcare provider for personalized medical advice. There are no well-documented interactions between the two medications, but individual circumstances may vary. Always follow your doctor's recommendations and report any unusual side effects.
The cost of CellCept (mycophenolate mofetil) without insurance can vary widely depending on the pharmacy and location, but it typically ranges from $1,000 to $2,000 for a month's supply. Prices may fluctuate based on dosage and pharmacy discounts. It's advisable to check with local pharmacies for the most accurate pricing, and some patients may qualify for assistance programs provided by the manufacturer.
Cellcept (mycophenolate mofetil) is often recommended to be taken on an empty stomach because food can affect its absorption, potentially reducing its effectiveness. Taking it without food ensures more consistent drug levels in the bloodstream, which is crucial for its role in suppressing the immune system, especially in transplant patients. Therefore, adhering to this guideline helps optimize the medication's therapeutic benefits.
Study of CellCept and prednisone as immunotherapy in the treatment of MG. Another is the study of Etanercept to determine if it improves muscle strength in patients with MG.
Cellcept (mycophenolate mofetil) pills typically have a shelf life of about 2 to 3 years from the date of manufacture, as indicated on the packaging. However, it's essential to check the expiration date printed on the bottle or blister pack and not to use the medication past that date. Proper storage, away from moisture and heat, can help maintain its efficacy during that time. Always consult a healthcare professional if you have questions about your medications.
(4E)-​6-​(4-​hydroxy-​6-​methoxy-​7-​methyl-​3-​oxo-​1,​3-​dihydro-​2-​benzofuran-​5-​yl)-​4-​methylhex-​4-​enoic acid. Courtesy of wikipedia
Yes. They are often given together to treat Lyme disease
The dose for Prograf (Tacrolimus) is decided on blood concentration - i.e via a blood test. The concentration of Prograf in your bloodsteam is very variable between patients, as it's based on bodyweight, whether you eat at the same time as taking the drug, what you eat, what other drugs you are on and other factors. It's not possible to generalise what dosage you should expect to be on two months post-transplant, except that the dose will still be quite high at this stage. (since you're only two months post-transplant). I'm not familiar with Cellcept in the long term - tried it a couple of times and it didn't work for me.
yes it is, my mom has had lupus fpr over 8 years and it has she just began her treatments about 6 months ago. They are working alot! : )
There are 4 Food and Drug Administration medications for the treatment of lupus:AspirinPrednisoneHydroxychloroquine (Plaquenil)Belimumab (Benlysta)Off label medications include prescription anti-inflammatories, rituxan (Rituxamab), cytoxan, azathioprine, methotrexate and other immunosuppressive medications.
Medications vary widely based on what organs are affected by the autoimmune activity. Antimalarials, prednisone and NSAIDS are used most commonly. Chemotherapies like methotrexate and cytoxan are sometimes used. Cellcept (mycophenolate mofetil) which is used to prevent organ transplant rejection is now being used for many lupus patients. New biologics are being developed which interrupt the autoimmune activity at the level of B cells. Benlysta is on its way to FDA approval and will be the first new medication developed and approved specifically for lupus since November 20, 1958.